Cannabidiol (CBD) Softgels

A unique oral dosage form that allows having tablets, capsules, granules or pellets inside a single, larger soft gelatin capsule. Unigel™ is the only patented technology for fixed dose combinations which incorporate the benefits of soft gelatin capsules. Created for patients and consumers who want...

Discover our Chewable Softgel Platform ChewgelsTM, chewable soft capsules as a solution and line extension to existing or new products. With new ingredients, special shapes and flavors, we can offer our customers a range of formulations for different therapeutic lines. But, when thinking about consumer...

At Fun-trition we are focused on offering a complete experience in every bite of our delicious gummies. From Gelatin, to Plant-based technologies to guilt-free, sugar-free gummy formulations we understand that good nutrition doesn't have to be boring. At Funtritiom, we don’t just manufacture gummies, we c...

Vegetarian softgels are becoming increasingly competitive with animal-based gels. ​As development efforts continue, additional areas of limitation may be overcome, such as the desire to use natural colorants and high-viscosity ingredients. ​ Meet our vegetarian softgel technolog...

Procaps, developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents, has partnered with CPHI Barcelona to support sustainability initiatives, to be highlighted at the CPHI Worldwide event in Barcelona in October 2023. 

Offering end-to-end solutions in Softgel technologies from development across delivery. Learn more about who we are.

In our packed out content sessions at CPHI Barcelona this year we focus on some of the hottest topics coming up in the pharma industry, with each track sponsored by a leading expert in the field.   

Get to know more about our expanded capabilities for proximity and to better serve our customers and prospect partners in their markets.

This article is aimed to offer a general review of the fixed dose combinations (FDC), the manufacturing technologies and their applications, benefits and setbacks as well as a case study to illustrate the product concept based on the new technological platform of Unigel®️ for FDCs in soft gelatin capsules

Discover how our passion for innovation turns into revolutionary technologies that are ideal for consumers health and nutrition. Unigel™ is the only technology available for fixed dose combinations, that allows multiple ingredients to co-exist in one single dose

The Pharma industry is shifting from volume to value – addressing smaller patient populations and rare diseases. 3D printing (3DP) technologies have a transformational role to play. However, 3DP comprises an array of different additive manufacturing technologies of which only some can be adapted to the use in pharmaceutics. This session will discuss the use of 3D printing in a hospital setting to prepare personalised therapies for paediatric patients. For the first time, 3D printing offers a feasible, rapid and automated approach to prepare oral tailored-dose therapies for patient improving safety and adherence to the treatment. Podcast aired as part of the CPHI Festival of Pharma

Join Frances Zipp, where she will delve into the latest innovations and developments in drug manufacturing and how the industry can embrace 4.0

The pharmaceutical industry faces significant challenges in bringing new drugs to market due to the complexities of the R&D process. These challenges include high costs, lengthy development timelines, and a low success rate. In response to these challenges, a new approach to R&D has emerged: R&D 4.0.
R&D 4.0 leverages advanced technologies such as Deep Learning, Machine Learning, Artificial Intelligence, 3D Printing; among others, to streamline the drug development process and reduce time-to-market. In this webinar, join Procaps Group to explore the role of these technologies to improve the pharmaceutical development process. We will showcase real-world case studies performed, including the utilization of three-dimensional printing technology in the development of complex and customized drug delivery systems. Additionally, we will discuss how Deep Learning algorithms can estimate moisture levels in gelatin mass at different stages of the manufacturing process using spectral data. This approach provides real-time data to optimize the production process and ensure consistent quality. Furthermore, we will explain how Machine Learning algorithms, specifically the Pearson correlation coefficient, are being used to analyse the interaction of different excipients in drug formulations. This analysis helps in optimizing drug formulations to improve stability and efficacy. Explore with Procaps Group the exciting potential of R&D 4.0 as a leading Softgel CDMO/CMO.
Discussion topics To gain an understanding of R&D 4.0 in the pharmaceutical industry, including its key principles and how it can help reduce time-to-market To learn about the benefits and challenges of utilizing advanced technologies such as 3D printing, Deep Learning, and Machine Learning in pharmaceutical development To explore real-world examples from Procaps on how these technologies have been used in pharmaceutical R&D, including in the development of complex drug delivery systems and the optimization of drug formulations specifically in Softgel advanced technologies Get a deeper insight on who Procaps Group is and how as a leading Softgel CDMO/CMO is incorporating these trends and technologies to achieve better time-to-market for its partners around the world

Join our focused session, where our expert will dive into Process Analytical Technology and how these innovations are ushering in a new era of manufacturing.
Why having the latest PAT systems can help improve quality and cost of current manufacturing practices What are the challenges when applying a risk-based approach to a PAT-based control strategy Understanding how AI can increase continuous processing through deep learning

Digital transformation is a key area of development in pharma, but potential can be limited by regulatory roadblocks, a talent gap and integration complexities. Join our experts to gain insights into overcoming challenges and implementing the latest technologies: Becoming tech-led, not led by technology Managing change effectively Talent acquisition and onboarding Scaling across the organisation to avoid silos

Join our panel of experts to explore the tangible opportunities AI brings to pharma manufacturing: Improving batch manufacturing processes Efficient quality assurance and regulatory compliance Defining the role of chatbots and the potential for improving training and compliance standards in manufacturing set-ups Reviewing how AI can improve patient engagement